Events Search and Views Navigation
May 2019
The misuse of existing antibiotics in clinical practice and the introduction of antibiotics into the environment in combination with the inherently adaptive nature of microorganisms has led to a major global health crisis with the evolution of antibiotic-resistant organisms. The crisis is driving demand for the development of new antibacterial therapies for the treatment of drug-resistant and emerging bacterial pathogens. This webinar will address the steps necessary to bring an antibacterial therapeutic from discovery to clinical trials and will discuss basic strategies for the development and execution of a pre-clinical antibacterial drug development program. Register Now About the [...]
Find out moreJune 2019
Noble Life Sciences will be attending Bio 2019. Noble is a preclinical CRO providing discovery to GLP safety toxicology studies to support small molecule, biologic, and cell/gene therapy development using a wide variety of in vitro and in vivo preclinical models. With our capabilities spanning from small to large animals, flow cytometry, live animal imaging, we could be your turnkey CRO partners in taking your preclinical program from discovery to IND enabling studies at an accelerated speed. Srujana Cherukuri, CEO of Noble Life Science will be at Bio 2019 on June 4, 2019. If you are looking for preclinical [...]
Find out moreNoble Life Sciences will be attending Diversity Alliance For Science 2019 East Coast Conference, a very interactive meeting where corporations and small and/or divers businesses build relationships to drive inclusive procurement practices. Noble is proud to be graduating from 2018 – 2019 mentorship program and feel fortunate to be mentored by Eli Lilly. Noble is a preclinical CRO providing discovery to GLP safety toxicology studies to support small molecule, biologic, and cell/gene therapy development using a wide variety of in vitro and in vivo preclinical models. With our capabilities spanning from small to large animals, flow cytometry, live animal [...]
Find out moreSeptember 2019
Noble Life Sciences is proud to be a Hosting Partner, Exhibitor of CAR-TCR Summit 2019. Noble is a preclinical CRO providing discovery to GLP safety toxicology studies to support small molecule, biologic, and cell/gene therapy development using a wide variety of in vitro and in vivo preclinical models. We offer a wide variety of cell line derived xenograft (CDX) and syngeneic models, CAR-T models, subcutaneous, orthotopic and disseminated models, and GvHD models to support oncology and immune-oncology therapeutic development. Noble has conducted over 100 CAR-T projects and with our capabilities spanning from small to large animals, flow cytometry, live [...]
Find out moreNovember 2019
Noble Life Sciences is Exhibiting at ACT 2019, 40th Annual Meeting. Noble Life Sciences is a preclinical CRO providing GLP Safety Toxicology Testing Services using small to large animal models to support small molecule, biologic, and cell and gene therapy products. Visit us at Booth # 503 to discuss your safety toxicology testing needs. Schedule a meeting to learn how Noble can help in moving forward your toxicology program at an accelerated pace. Stay tuned, we will be updating this page with more information as we get closer to the meeting.
Find out more